$mCig, Inc. Signs E! Reality Star of "Keeping Up With The

New Post Public Reply Private Reply Replies (0) Message Board
MattySimone
$mCig, Inc. Signs E! Reality Star of "Keeping Up With The Kardashians"

Aug 12, 2014 (GLOBE NEWSWIRE via COMTEX) --

- Public Relations Expert Jonathan Cheban joins The VitaCig Team as Ambassador and PR Consultant

- Stars on the E! Television Hits "Spin Crowd" and "Keeping Up With The Kardashians"

- Company Now Represented by 4 World-Famous Ambassadors

BELLEVUE, Wash., Aug. 12, 2014 (GLOBE NEWSWIRE) -- mCig, Inc. (otcqb:MCIG) is pleased to announce Jonathan Cheban, E! Reality Star of "Keeping Up With The Kardashians" is the company's latest brand ambassador and public relations consultant.

Cheban, best known as close friend to Kim Kardashian and star of the hit television show 'Keeping Up With The Kardashians' is a global celebrity and public relations expert with nearly twenty years of experience managing world famous celebrities, events, and brand launches. After graduating from Hofstra University in 1995, Cheban worked in the entertainment, modeling and public relations industries for several years in both New York and Los Angeles. He started his career working with Peggy Siegal, a high-powered publicist in New York. In the late 1990's, Cheban left Siegal and formed his own PR firm with two other publicists. He was soon representing such big-name clients as Banana Republic, Baccarat Crystal, Oscar de la Hoya, Backstreet Boys, Playboy, and clubs like Spa and Luan. However, he split with his partners in 2001 and he founded his own public relations firm, Command PR and had his own television show on the E! Network (Spin Crowd). Currently, Cheban remains a consultant with Command PR while he is preparing to launch his own firm. To learn more about Jonathan Cheban visit: http://www.thedishh.com/ or his Wikipedia page here: http://en.wikipedia.org/wiki/Jonathan_Cheban .

Having joined mCig, Inc. as a business partner and ambassador, Cheban will initiate national product endorsements by means of his social media platforms and through various media distribution channels. Additionally, Cheban will be introducing the VitaCig brand to his circle of friends and media partners.

"Since I'm always jumping in between different projects I'm working on, going to an event late in the evening, or filming, I constantly need a quick and healthy pick me up. That's why I have decided to partner with VitaCig, makers of a vitamin electronic cigarette that only has vitamins and natural flavoring – that's it! Everyone that knows me knows I love food, and the flavors like orange, peppermint, and blueberry are amazing! It also feels good to have a relaxing moment of peace while enjoying a VitaCig, which I have now crowned my "healthy habit". I would like to thank VitaCig's CEO Paul Rosenberg for welcoming me as brand ambassador. I look forward to assisting VitaCig in becoming more popular and to help introduce VitaCig to my friends, fans, and followers," said Jonathan Cheban.

"We couldn't be more excited to add Jonathan Cheban to our growing list of brand ambassadors. Jonathan's a respected tastemaker and loves to promote a healthy living, which is right in line with the message of VitaCig. I'm confident Jonathan is going to expand the reach of this brand to a whole new audience, and help with the growth of VitaCig to new markets globally," said Jordan "DJ Swivel" Young, mCig's first brand ambassador.

"We are thrilled to be welcoming Jonathan to the mCig/VitaCig team. Jonathan represents our push into more traditional media outlets as our products gain a wider following and are becoming more recognizable by consumers. Jonathan is often referred to as Kim Kardashians "best friend", but his knowledge of public relations and strategic brand marketing extends much beyond reality television. We look forward to working closely with Jonathan and leveraging his network to further expand our family of brand ambassadors," said Paul Rosenberg, Chairman and CEO of mCig, Inc.

Filing Update

The company would like to update its shareholders that its form 10-K will be filed by Friday August 15, 2014 and its 30 page Annual Report will be published next week.

About mCig, Inc.

mCig, Inc. (otcqb:MCIG) is a technology company focused on two long-term secular trends sweeping the globe: (1) The decriminalization and legalization of marijuana for medicinal or recreational purposes (2) The adoption of electronic vaporizing cigarettes (commonly known as "eCigs" by the world's 1.2 Billion smokers. The company manufactures and retails the mCig – the world's most affordable vaporizer priced at only $10. Designed in the USA – the mCig provides a superior smoking experience by heating plant material, waxes, and oils delivering a smoother inhalation experience. The company also owns Vapolution, Inc. which manufactures and retails home-use vaporizers such as the Vapolution 2.0. Through its wholly owned subsidiary, VitaCig, Inc. the company manufactures and retails the VitaCig, a $5 nicotine-free eCig that delivers a water-vapor mixed with vitamins and natural flavors. See more at: http://www.mCig.org , www.Vapolution.com , and www.VitaCig.org .

The company believes that a well regulated marijuana industry is emerging as more states follow the lead of Washington and Colorado in legalizing marijuana. A similar trend is developing within the eCig industry following the first acquisition of an electronic cigarette brand (Blucigs) by a traditional tobacco company Lorillard Inc. for $135 million followed by another acquisition in February 2014 by Altria Group Inc. of Green Smoke for $150 million. Wells Fargo analyst Bonnie Herzog estimates that eCig sales may rise from $1 Billion in 2013 to $10 billion over the next three years.

mCig, Inc. (otcqb:MCIG) has positioned itself as a first mover at the intersection of these two trends and hopes to create shareholder value by making the mCig one of the leading choices for electronic consumption of plant material. - See more at: http://www.mcig.org/investors/investor-opportunity-subpage/ .

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
I own shares of the stock I post about and I may or may not buy or sell those shares without notification
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 200

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 245

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 238

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 286

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 151

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading

Top 5 Most Recently Viewed Articles

Avacta Therapeutics Showcases Promising FAP-Dox Data at ESMO

Updated Category News Views 196

Avacta Therapeutics Presents FAP-Dox Data at International Congress Avacta Therapeutics, a pioneering life sciences company, is set to present an exciting update regarding their innovative drug FAP-Dox (AVA6000) at an esteemed international oncology congress. This event will spotlight groundbreaking research and clinical advancements in targeted cancer treatments that can...

Continue Reading
Qvinci and Harmonyze Join Forces to Revolutionize Franchise Coaching

Updated Category News Views 163

Strategic Collaboration Between Qvinci and Harmonyze In a remarkable development, Qvinci Software, renowned for its innovative franchise financial performance solutions, has announced a pivotal partnership with Harmonyze, an AI-driven performance coaching platform. This collaboration is designed to assist franchisors in transforming intricate financial insights into...

Continue Reading
Citi Remains Optimistic on Capgemini Amid Margin Growth

Updated Category News Views 198

Outlook for Capgemini Stock Citi analyst Balajee Tirupati has recently made adjustments to the price target for Capgemini SE (CAP:FP) (OTC: CAPMF), reducing it to €215 from €225. Despite this revision, Citi has maintained a positive stance, continuing to endorse a Buy rating for Capgemini's stock. Weaker Third-Quarter Update Capgemini's recent third-quarter report for...

Continue Reading
Beyond Oil Marks Key Milestone with Initial Shipment to T&J Oil

Updated Category News Views 252

Beyond Oil's Successful Expansion into the Australian Market Following its commitment to health and sustainability, Beyond Oil Ltd. (CSE: BOIL, OTCQB: BEOLF) has successfully delivered its first shipment of 5.4 tonnes of proprietary oil treatment products to T&J Oil Pty Ltd. This marks an important leap for the company as it steps into the Australian distribution arena,...

Continue Reading
Donaldson Partners with the Special Olympics to Inspire Change

Updated Category News Views 87

Donaldson's Commitment to Community Engagement Donaldson Company, Inc. (NYSE: DCI), a leader in innovative filtration solutions, has taken a significant step towards community engagement by announcing its partnership with the 2026 Special Olympics USA Games. This event is set to create a platform for inclusion, offering athletes with diverse abilities an opportunity to...

Continue Reading